LB Pharmaceuticals Inc
- Last sale
- Nov 2, 2026 · -1.54%
- Market cap
- $1.26B
- 32.27M shares
- Filings
- 146
—
—
—Q3 2026N/M FY25 yoy
—
—
—Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026+988.8% FY25 yoy
- $1.26B
- —
- —
- 3.0×
- -2.80%
- —
FY2025 figures · derived
Price
Nov 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $16,744,000 | reported | |
| FY 2024 | 2024-12-31 | $51,171,000 | reported |
Pharmaceutical preparations
LB Pharmaceuticals Inc is the 135th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
MNKDMannkind Corp$349.0M22.2%1.7%$1.3BKARDKardigan, Inc.———$1.3BOMEROmeros Corp———$1.3BURGNUroGen Pharma Ltd.$109.8M21.4%139.8%$1.3BCMPSCOMPASS Pathways plc———$1.3BNKTRNektar Therapeutics$55.2M43.9%297.1%$1.3B
LBRXLB Pharmaceuticals Inc (this company)———$1.3B
OPKOpko Health, Inc.$606.9M14.9%37.2%$1.2BANROAlto Neuroscience, Inc.———$1.2BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
LB Pharmaceuticals Inc · CIK 1691082 · Engraved from SEC EDGAR